Development of new personalized computational digital technologies and machine learning approaches for the prediction and treatment of organ socially significant diseases.

Nanoparticles, a critical bone defect

We study the mechanisms of development of hereditary corneal pathologies (corneal dystrophy, keratoconus) and their genetic structure. We are developing approaches to antitumor immunotherapy, including the use of antitumor T cells. We are engaged in the genomics and population structure of microsatellite repeat expansions, including in schizophrenia. We are developing new approaches to bioinformatic data analysis. We are able to analyze the hla of macaques using nanopore readings.